Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer—a Critical Review
作者： Adrian Szczepaniak , Jakub Fichna
DOI: 10.3390/BIOM9090398
关键词:
摘要: In recent years, there has been a significant increase in the clinical use of organometallic compounds and metal complexes for therapeutic purposes including treatment inflammatory bowel diseases (IBD). Their action is based on inhibition inflow pro-inflammatory cytokines, elimination free radicals or modulation intestinal microbiota. addition, these are intended diagnosis colorectal cancer (CRC) which often consequence IBD. The aim this study to critically discuss findings IBD CRC suggest future trends drug design.
mdpi.com
sci-hub.se 参考文章(102)
Chung-Hang Leung, Sheng Lin, Hai-Jing Zhong, Dik-Lung Ma, Metal complexes as potential modulators of inflammatory and autoimmune responses Chemical Science. ,vol. 6, pp. 871- 884 ,(2015) , 10.1039/C4SC03094J
P.-S. Kuhn, V. Pichler, A. Roller, M. Hejl, M. A. Jakupec, W. Kandioller, B. K. Keppler, Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential. Dalton Transactions. ,vol. 44, pp. 659- 668 ,(2015) , 10.1039/C4DT01645A
Fuyi Wang, Haimei Chen, Simon Parsons, Iain D. H. Oswald, James E. Davidson, Peter J. Sadler, Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Chemistry: A European Journal. ,vol. 9, pp. 5810- 5820 ,(2003) , 10.1002/CHEM.200304724
Min-Hyuk Yoo, Xue-Ming Xu, Bradley A. Carlson, Andrew D. Patterson, Vadim N. Gladyshev, Dolph L. Hatfield, Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication. PLOS ONE. ,vol. 2, ,(2007) , 10.1371/JOURNAL.PONE.0001112
N. Selcan Turker, Pedram Heidari, Raju Kucherlapati, Melanie Kucherlapati, Umar Mahmood, An EGFR targeted PET imaging probe for the detection of colonic adenocarcinomas in the setting of colitis. Theranostics. ,vol. 4, pp. 893- 903 ,(2014) , 10.7150/THNO.9425
Frederike Lentz, Anne Drescher, Andreas Lindauer, Magdalena Henke, Ralf A Hilger, Christian G Hartinger, Max E Scheulen, Christian Dittrich, Bernhard K Keppler, Ulrich Jaehde, Central European Society for Anticancer Drug Research-EWIV, Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study. Anti-Cancer Drugs. ,vol. 20, pp. 97- 103 ,(2009) , 10.1097/CAD.0B013E328322FBC5
Eran Elinav, Roni Nowarski, Christoph A. Thaiss, Bo Hu, Chengcheng Jin, Richard A. Flavell, Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature Reviews Cancer. ,vol. 13, pp. 759- 771 ,(2013) , 10.1038/NRC3611
Stephen G. Chaney, Sharon L. Campbell, Ekaterina Bassett, Yibing Wu, Recognition and processing of cisplatin- and oxaliplatin-DNA adducts Critical Reviews in Oncology Hematology. ,vol. 53, pp. 3- 11 ,(2005) , 10.1016/J.CRITREVONC.2004.08.008
M. Chiba, S. Hoshina, M. Kono, M. Tobita, T. Fukushima, M. Iizuka, S. Watanabe, Staphylococcus aureus in Inflammatory Bowel Disease Scandinavian Journal of Gastroenterology. ,vol. 36, pp. 615- 620 ,(2001) , 10.1080/003655201750163079
M P Conte, S Schippa, I Zamboni, M Penta, F Chiarini, L Seganti, J Osborn, P Falconieri, O Borrelli, S Cucchiara, Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease Gut. ,vol. 55, pp. 1760- 1767 ,(2006) , 10.1136/GUT.2005.078824